deltatrials
Completed OBSERVATIONAL NCT06671808

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

HIV Infection Accompanied by Multi-Drug Resistant Tuberculosis: a Decadal Systematic Review and Meta-Analysis

Sponsor: Zahedan University of Medical Sciences

Conditions HIV Infection MDR-TB
Interventions Examination of HIV Infection in Patients with Multi-Drug Resistant Tuberculosis (MDR-TB)
Updated 2 times since 2024 Last updated: Nov 1, 2024 Started: May 15, 2024 Primary completion: Aug 22, 2024 Completion: Sep 3, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates HIV Infection and MDR-TB and is currently completed. Zahedan University of Medical Sciences leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Dec 2024 — Sep 2025 [monthly]

    Completed

    First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zahedan University of Medical Sciences
Data source: Zahedan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations